Patients with pituitary adenomas were identified by histopathology and magnetic resonance imaging (MRI) at the First Affiliated Hospital of Soochow University between January 2021 and April 2022. All participants underwent pre- and postoperative ophthalmic examinations, including visual acuity and visual field measurements. The visual field map was divided into the superior temporal region (0–90°), inferior temporal region (270–360°), superior nasal region (90–180°), and inferior nasal regions (180–270°). Each region was divided into three ranges (0–30°, 30–60°, 60–90°, 90–120°, 120–150°, 150–180°, 180–210°, 210–240°, 240–270°, 270–300°, 300–330°, and 330–360°).
The inclusion criteria were as follows: (1) pituitary adenomas identified by histopathological examination and MRI; (2) evidence of preoperative VF impairment; (3) endoscopic endonasal surgery; and (4) totally resection identified by postoperative MRI.
Exclusion criteria were as follows: (1) patients without defects in the preoperative visual field; (2) unavailable data or insufficient ophthalmic examinations; (3) previous treatment for ocular lesions and previous ocular surgery; (4) high myopia (>6 diopters); (5) congenital eye disease; (6) glaucoma, any optic disc anomaly, and macular disease.
The inclusion criteria were as follows: (1) pituitary adenomas identified by histopathological examination and MRI; (2) evidence of preoperative VF impairment; (3) endoscopic endonasal surgery; and (4) totally resection identified by postoperative MRI.
Exclusion criteria were as follows: (1) patients without defects in the preoperative visual field; (2) unavailable data or insufficient ophthalmic examinations; (3) previous treatment for ocular lesions and previous ocular surgery; (4) high myopia (>6 diopters); (5) congenital eye disease; (6) glaucoma, any optic disc anomaly, and macular disease.
Free full text: Click here
